Low-Dose Thalidomide Treatment for Advanced Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|65|3|242-249

ISSN： 0030-2414

Source： Oncology, Vol.65, Iss.3, 2003-12, pp. : 242-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Tolerability of Low-Dose Thalidomide as First-Line Systemic Treatment of Patients with Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 67-71

Karger

Access to resources Recommend Favorite

Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 82, Iss. 2, 2012-02 ,pp. : 119-125

Karger

Access to resources Recommend Favorite

Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 148-153

Karger

Access to resources Recommend Favorite

Treatment of Advanced Hepatocellular Carcinoma with Biweekly High-Dose Gemcitabine

By  

Oncology, Vol. 60, Iss. 4, 2001-06 ,pp. : 313-315

Karger

Access to resources Recommend Favorite

Low-Dose, Long-Term, Intermittent Interferon-alpha-2b Therapy after Radical Treatment by Radiofrequency Ablation Delays Clinical Recurrence in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

By  

Intervirology, Vol. 48, Iss. 1, 2005-03 ,pp. : 64-70

Karger

Access to resources Recommend Favorite